Psychopharmacology and Psychiatry Updates

265 Episodio

1. Association Between Mood Disorders and COVID-19

   Pubblicato: 16/06/2022
2. Antidepressants and Naltrexone for Stimulant Use Disorder

   Pubblicato: 11/06/2022
3. CANMAT Task Force Recommendations for the Use of Ketamine

   Pubblicato: 06/06/2022
4. Stimulant Replacement Therapies for Methamphetamine and Amphetamine Use Disorder

   Pubblicato: 01/06/2022
5. Premenstrual Mood Syndromes

   Pubblicato: 27/05/2022
6. Stimulant Use Disorder: Diagnosis and Assessment

   Pubblicato: 22/05/2022
7. Zuranolone for Postpartum Depression

   Pubblicato: 17/05/2022
8. Long-Term Treatment of First Episode of Psychosis

   Pubblicato: 12/05/2022
9. The Effects of Antipsychotic Treatment on the Brain of Patients With First-Episode Schizophrenia

   Pubblicato: 07/05/2022
10. Health Issues in First Episode of Psychosis

    Pubblicato: 02/05/2022
11. Psychopharmacology for Treatment-Resistant Early Psychosis

    Pubblicato: 27/04/2022
12. Assessing and Treating Adult ADHD

    Pubblicato: 22/04/2022
13. Medications for Binge Eating Disorder

    Pubblicato: 17/04/2022
14. Antipsychotics for First Episodes of Psychosis

    Pubblicato: 12/04/2022
15. Effects on Suicidal Risk With Different Medications

    Pubblicato: 07/04/2022
16. Risks of Using Cannabinoids

    Pubblicato: 02/04/2022
17. Lithium: How to Manage Dosage

    Pubblicato: 28/03/2022
18. CBD as a Medication

    Pubblicato: 23/03/2022
19. SSRIs and Suicidality

    Pubblicato: 18/03/2022
20. Cannabis and Cognition

    Pubblicato: 13/03/2022